hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways

@inproceedings{Park2017hMAGEA2PP,
  title={hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways},
  author={Song Hwa Park and Yonghun Sung and Jain Jeong and Minjee Choi and Jinhee Lee and Wookbong Kwon and Soyoung Jang and Si Jun Park and Hyeng-Soo Kim and Mee-Hyun Lee and Dong Joon Kim and Kangdong Liu and Sung-Hyun Kim and Ziming Dong and Zae Young Ryoo and Myoung Ok Kim},
  booktitle={Oncotarget},
  year={2017}
}
Breast cancer is the most abundant cancer worldwide and a severe problem for women. Notably, breast cancer has a high mortality rate, mainly because of tumor progression and metastasis. Triple-negative breast cancer (TNBC) is highly progressive and lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Therefore, there are no established therapeutic targets against TNBC. In this study, we investigated whether the… CONTINUE READING